Latest Strategy News

Monadelphous Group has landed over $200 million in new contracts spanning wind turbine installation, maintenance, and construction services across Australia and Papua New Guinea.

BlackRock Investment Management (Australia) has announced estimated cash distributions for 16 Australian iShares ETFs, with payments scheduled for mid-July 2026. Investors must be registered by 2 July and ensure bank details and tax certifications are up to date.

ARN Media is selling its Hong Kong out-of-home advertising business, Cody HK, to DFI Retail Group for HK$30.2 million, marking a strategic exit from non-core assets to sharpen focus on Australian operations.

American Tungsten & Antimony Ltd has inked an underwriting deal with GBA Capital to ensure full subscription of up to 69 million AT4N options expiring this month, securing potential capital injection amid its US critical minerals push.

Bravura Solutions plans to list on the London Stock Exchange's AIM market by late July 2026, aiming to tap into UK and European institutional investors while maintaining its ASX primary listing.

Taiton Resources has issued nearly 1.8 million shares and close to 900,000 options to a sophisticated investor, part of an ongoing placement raising $125,000 so far. Additional shares and options will follow as funds come in.

JPMorgan Asset Management has released updated estimated annual cash distributions for six of its ASX-listed ETFs for the financial year ending 30 June 2026, with amounts varying widely between funds and one yielding no distribution.

Elders Limited has finalised the sale of Killara Feedlot to Australian Meat Group, marking a key step in its strategy to reduce net debt.

Bougainville Copper Limited’s key exploration licence EL01 is suspended after a 25-year large-scale mining lease was granted to Bougainville Minerals Limited over the same land, prompting the company to form an independent committee to assess legal and strategic options.

Salt Listed Funds released its 2026 annual report highlighting governance changes, investment policy updates including Treasury Units and Carbon-Related Businesses, and a notable decline in the Carbon Fund’s unit price over the year.

Aroa Biosurgery delivered a breakout FY26 with NZ$104 million revenue, driven by strong Myriad sales and clinical trial success, setting the stage for ambitious FY27 growth.

The Alternative Investment Trust (AIQ) posted a 2.0% diluted NTA return in 2025, weighed down by an 8% appreciation of the Australian dollar against its largely USD-denominated portfolio. The trust bolstered its capital base with a A$34.5 million rights issue and increased exposure to the WSS Master Fund.